Travere Therapeutics, Inc.
US ˙ NasdaqGM ˙ US89422G1076

SecurityTVTX / Travere Therapeutics, Inc.
InstitutionMillennium Management Llc
ManagerIsrael Englander
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Millennium Management Llc ownership in TVTX / Travere Therapeutics, Inc.

On May 15, 2026 - Millennium Management Llc filed a 13F-HR form disclosing ownership of 0 shares of Travere Therapeutics, Inc. (US:TVTX) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 136,065 shares of Travere Therapeutics, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Millennium Management Llc has a history of taking positions in derivatives of the underlying security (TVTX) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 20,000 of underlying shares valued at $594,200 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

TVTX / Travere Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 0 -136,065 -100.00 0 -100.00
2026-02-17 2025-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 136,065 2,196 1.64 5,199 62.52 0.0022
2025-11-14 2025-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 133,869 -75,122 -35.95 3,199 3.43 0.0014
2025-08-14 2025-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 208,991 149,159 249.30 3,093 188.53 0.0015
2025-05-15 2025-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 59,832 -566,224 -90.44 1,072 -90.17 0.0006
2025-02-14 2024-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 626,056 511,443 446.23 10,906 580.29 0.0053
2024-11-14 2024-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 114,613 -2,834,722 -96.11 1,603 -93.39 0.0008
2024-08-14 2024-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 2,949,335 747,406 33.94 24,244 42.81 0.0112
2024-05-15 2024-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 2,201,929 907,343 70.09 16,977 45.87 0.0073
2024-02-14 2023-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 1,294,586 -2,058,795 -61.39 11,638 -61.18 0.0050
2023-11-14 2023-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 3,353,381 2,728,778 436.88 29,979 212.51 0.0151
2023-08-14 2023-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 624,603 -499,735 -44.45 9,594 -62.06 0.0047
2023-05-15 2023-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 1,124,338 263,293 30.58 25,286 39.64 0.0145
2023-02-14 2022-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 861,045 262,046 43.75 18,108 22.69 0.0100
2022-11-14 2022-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 598,999 406,183 210.66 14,759 215.90 0.0087
2022-08-15 2022-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 192,816 -650,813 -77.14 4,672 -78.51 0.0029
2022-05-16 2022-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 843,629 553,326 190.60 21,740 141.26 0.0115
2022-02-14 2021-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 290,303 126,355 77.07 9,011 126.63 0.0046
2021-11-15 2021-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 163,948 137,577 521.70 3,976 932.73 0.0024
2021-08-16 2021-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 26,371 -409,311 -93.95 385 -96.46 0.0002
2021-05-17 2021-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 435,682 -291,494 -40.09 10,879 -45.11 0.0078
2021-02-16 2020-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 727,176 -138,933 -16.04 19,819 23.96 0.0143
2020-11-16 2020-09-30 13F RETROPHIN COM 761299106 866,109 -333,752 -27.82 15,988 -34.71 0.0197
2020-08-14 2020-06-30 13F RETROPHIN COM 761299106 1,199,861 71,987 6.38 24,489 48.82 0.0336
2020-05-14 2020-03-31 13F RETROPHIN COM 761299106 1,127,874 -596,411 -34.59 16,456 -32.79 0.0370
2020-02-14 2019-12-31 13F RETROPHIN COM 761299106 1,724,285 1,209,501 234.95 24,485 310.41 0.0306
2019-11-14 2019-09-30 13F RETROPHIN COM 761299106 514,784 -35,786 -6.50 5,966 -46.06 0.0094
2019-08-15 2019-06-30 13F/A-1 RETROPHIN COM 761299106 550,570 333,937 154.15 11,061 125.64 0.0166
2019-08-14 2019-06-30 13F FATE THERAPEUTICS COM 761299106 2,022,985 1,806,352 41,067
2019-05-14 2019-03-31 13F RETROPHIN COM 761299106 216,633 -74,827 -25.67 4,902 -25.68 0.0073
2019-02-15 2018-12-31 13F/A-1 RETROPHIN COM 761299106 291,460 -228,159 -43.91 6,596 -55.82 0.0103
2019-02-14 2018-12-31 13F RETROPHIN COM 761299106 291,460 6,596
2018-11-14 2018-09-30 13F RETROPHIN COM 761299106 519,619 -79,405 -13.26 14,929 -8.57 0.0183
2018-08-14 2018-06-30 13F RETROPHIN COM 761299106 599,024 -338,116 -36.08 16,329 -22.07 0.0213
2018-05-15 2018-03-31 13F RETROPHIN COM 761299106 937,140 378,880 67.87 20,954 78.13 0.0280
2018-02-14 2017-12-31 13F RETROPHIN COM 761299106 558,260 9,926 1.81 11,763 -13.81 0.0162
2017-11-14 2017-09-30 13F RETROPHIN COM 761299106 548,334 260,236 90.33 13,648 144.33 0.0208
2017-08-14 2017-06-30 13F RETROPHIN COM 761299106 288,098 -328,865 -53.30 5,586 -50.95 0.0100
2017-05-15 2017-03-31 13F RETROPHIN COM 761299106 616,963 -248,198 -28.69 11,389 -30.46 0.0209
2017-02-14 2016-12-31 13F RETROPHIN COM 761299106 865,161 -330,817 -27.66 16,377 -38.81 0.0343
2016-11-14 2016-09-30 13F RETROPHIN COM 761299106 1,195,978 419,684 54.06 26,766 93.59 0.0449
2016-08-15 2016-06-30 13F RETROPHIN COM 761299106 776,294 433,464 126.44 13,826 195.24 0.0316
2016-05-16 2016-03-31 13F RETROPHIN COM 761299106 342,830 -140,469 -29.06 4,683 -49.77 0.0117
2016-02-16 2015-12-31 13F RETROPHIN COM 761299106 483,299 21,165 4.58 9,323 -0.43 0.0196
2015-11-16 2015-09-30 13F RETROPHIN COM 761299106 462,134 -367,440 -44.29 9,363 -65.95 0.0181
2015-08-14 2015-06-30 13F RETROPHIN COM 761299106 829,574 -110,828 -11.79 27,500 22.05 0.0520
2015-05-15 2015-03-31 13F RETROPHIN COM 761299106 940,402 940,402 0.00 22,532 0.0419
2014-08-14 2014-06-30 13F RETROPHIN COM 761299106 0 -25,700 -100.00 0 -100.00
2014-05-15 2014-03-31 13F RETROPHIN COM 761299106 25,700 25,700 545 0.0016
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2024-02-14 2023-12-31 13F TRAVERE THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-14 2023-09-30 13F TRAVERE THERAPEUTICS COM Call 15,800 141 n/a n/a n/a
2023-02-14 2022-12-31 13F TRAVERE THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-11-14 2022-09-30 13F TRAVERE THERAPEUTICS COM Call 100,000 2,464 n/a n/a n/a
2020-02-14 2019-12-31 13F RETROPHIN COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-11-14 2019-09-30 13F RETROPHIN COM Call 50,000 0.00 579 -42.39 n/a n/a n/a
2019-08-15 2019-06-30 13F/A RETROPHIN COM Call 50,000 1,005 n/a n/a n/a
2019-08-14 2019-06-30 13F SELECT SECTOR SPDR TR ENERGY Call 1,398,500 89,098 n/a n/a n/a
2017-02-14 2016-12-31 13F RETROPHIN COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2016-11-14 2016-09-30 13F RETROPHIN COM Call 243,500 305.83 5,450 409.82 n/a n/a n/a
2016-08-15 2016-06-30 13F RETROPHIN COM Call 60,000 1,069 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F TRAVERE THERAPEUTICS COM Put 20,000 -81.82 594 -85.87 n/a n/a n/a
2026-02-17 2025-12-31 13F TRAVERE THERAPEUTICS COM Put 110,000 9.45 4,203 75.05 n/a n/a n/a
2025-11-14 2025-09-30 13F TRAVERE THERAPEUTICS COM Put 100,500 2,402 n/a n/a n/a
2024-02-14 2023-12-31 13F TRAVERE THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-14 2023-09-30 13F TRAVERE THERAPEUTICS COM Put 266,100 2,379 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.